Systematic review and meta-analysis: Rate and rhythm control have comparable effects on mortality and stroke in atrial fibrillation but better data are needed

Evidence-Based Medicine

Volumn 19, Issue 6, 2014, Pages 222-223

  Kotecha, Dipak ^a,b   Kirchhof, Paul ^a,c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; HEART ATRIUM FIBRILLATION; HEART RATE; HEART RHYTHM; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PULMONARY VEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; ATRIAL FIBRILLATION; CARDIOVERSION;

ANTIARRHYTHMIC AGENT;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTRIC COUNTERSHOCK; HUMANS;

EID: 84911384790     PISSN: 13565524     EISSN: 14736810     Source Type: Journal    
DOI: 10.1136/ebmed-2014-110062     Document Type: Article

References (8)

1. Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369-429.
2. Davies HT, Crombie IK, Tavakoli M. When can odds ratios mislead? BMJ 1998;316:989-91.
3. de Denus S, Sanoski CA, Carlsson J, et al. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 2005;165:258-62.
4. Chatterjee S, Sardar P, Lichstein E, et al. Pharmacologic rate versus rhythm-control strategies in atrial fibrillation: an updated comprehensive review and meta-analysis. Pacing Clin Electrophysiol 2013;36:122-33.
5. Calkins H, Reynolds MR, Spector P, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-Analyses. Circ Arrhythm Electrophysiol 2009;2:349-61.
6. Kirchhof P, Breithardt G, Camm AJ, et al. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. Am Heart J 2013;166:442-8.
7. Krijthe BP, Kunst A, Benjamin EJ, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746-51.
8. Kotecha D, Manzano L, Altman DG, et al. Beta-Blockers in Heart Failure Collaborative Group. Individual patient data meta-analysis of beta-blockers in heart failure: rationale and design. Syst Rev 2013;2:7.